How does carrier status for recessive disorders influence reproductive decisions? A systematic review of the literature

被引:19
作者
Cannon, Jeffrey [1 ]
Van Steijvoort, Eva [1 ]
Borry, Pascal [1 ]
Chokoshvili, Davit [1 ]
机构
[1] Katholieke Univ Leuven, Ctr Biomed Eth & Law, Dept Publ Hlth & Primary Care, Kapucijnenvoer 35 Box 7001, B-3000 Leuven, Belgium
关键词
Carrier screening; reproductive decision-making; prenatal diagnosis; pre-implantation genetic testing; FRAGILE-X-SYNDROME; TAY-SACHS-DISEASE; CYSTIC-FIBROSIS; SCREENING-PROGRAM; GAUCHER-DISEASE; PRENATAL-DIAGNOSIS; BETA-THALASSEMIA; POPULATION; EXPERIENCE; COUPLES;
D O I
10.1080/14737159.2020.1690456
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Introduction: Carrier screening for recessive disorders is undertaken by prospective parents to inform their reproductive decisions. With the growing availability of affordable and comprehensive expanded carrier screening (ECS), it is expected that carrier screening will become a standard practice in the future. However, the impact of positive carrier screening results on the reproductive decisions of at-risk couples (ARCs) remains underexplored. Areas covered: We performed a systematic literature review to identify peer-reviewed publications describing the reproductive decisions of ARCs. Our search identified 19 relevant publications spanning the period 1994-2018. By synthesizing available evidence, we found that most ARCs chose to prevent the birth of an affected child and the decision to utilize preventive reproductive options was strongly influenced by the clinical nature of a disorder. However, there was also some heterogeneity in reproductive decisions within the same recessive disorders, suggesting that choices of ARCs can be influenced by factors other than the clinical nature of a disorder. Expert opinion: ECS is becoming increasingly common, which will result in the routine identification of many ARCs. Reproductive decision-making by ARCs is a complex and emotionally challenging process, highlighting the critical role of genetic counseling in the care for these potentially vulnerable patients.
引用
收藏
页码:1117 / 1129
页数:13
相关论文
共 45 条
  • [1] Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests
    Archibald, Alison Dalton
    Smith, Melanie Jane
    Burgess, Trent
    Scarff, Katrina Louise
    Elliott, Justine
    Hunt, Clare Elizabeth
    Barns-Jenkins, Caitlin
    Holt, Chelsea
    Sandoval, Karina
    Kumar, Vanessa Siva
    Ward, Lisa
    Allen, Emily Caroline
    Collis, Sarah Valerie
    Cowie, Shannon
    Francis, David
    Delatycki, Martin B.
    Yiu, Eppie Mildred
    Massie, R. John
    Pertile, Mark Domenic
    du Sart, Desiree
    Bruno, Damien
    Amor, David. J.
    [J]. GENETICS IN MEDICINE, 2018, 20 (05) : 513 - 523
  • [2] Clinical impact and cost-effectiveness of a 176-condition expanded carrier screen
    Beauchamp, Kyle A.
    Taber, Katherine A. Johansen
    Muzzey, Dale
    [J]. GENETICS IN MEDICINE, 2019, 21 (09) : 1948 - 1957
  • [3] Preconceptional genetic carrier testing and the commercial offer directly-to-consumers
    Borry, Pascal
    Henneman, Lidewij
    Lakeman, Phillis
    ten Kate, Leo P.
    Cornel, Martina C.
    Howard, Heidi C.
    [J]. HUMAN REPRODUCTION, 2011, 26 (05) : 972 - 977
  • [4] Prenatal screening for cystic fibrosis: 5 years' experience reviewed
    Brock, DJH
    [J]. LANCET, 1996, 347 (8995) : 148 - 150
  • [5] Chokoshvili D, 2018, MED REPROD GYNECOLOG, V20, P334
  • [6] Reproductive autonomy in expanded carrier screening: more than meets the eye?
    Chokoshvili, Davit
    Vears, Danya F.
    Borry, Pascal
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2018, 18 (12) : 993 - 994
  • [7] A systematic analysis of online marketing materials used by providers of expanded carrier screening
    Chokoshvili, Davit
    Borry, Pascal
    Vears, Danya F.
    [J]. GENETICS IN MEDICINE, 2018, 20 (09) : 976 - 984
  • [8] Expanded carrier screening for monogenic disorders: where are we now?
    Chokoshvili, Davit
    Vears, Danya
    Borry, Pascal
    [J]. PRENATAL DIAGNOSIS, 2018, 38 (01) : 59 - 66
  • [9] Growing complexity of (expanded) carrier screening: Direct-to-consumer, physician-mediated, and clinic-based offers
    Chokoshvili, Davit
    Vears, Danya F.
    Borry, Pascal
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2017, 44 : 57 - 67
  • [10] Outcomes of a cystic fibrosis carrier testing clinic for couples
    Christie, Louise M.
    Ingrey, Angela J.
    Turner, Gillian M.
    Proos, Anne L.
    Watts, Gloria E.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2009, 191 (09) : 499 - 501